Summary
INVO Fertility Inc reported a substantial market reaction after shareholders voted to raise the company’s authorized common stock, a move followed by a formal filing to amend its Articles of Incorporation. The announcement, which company filings show was decided at a special meeting on January 22, 2026, coincided with a 63.6% gain in the stock during Tuesday premarket trading.
Meeting actions and corporate filings
At the special meeting, stockholders approved an increase in authorized shares of common stock from 6,250,000 to 250,000,000. Following the vote, the company filed a Certificate of Amendment to its Articles of Incorporation to implement the change.
Shareholders also voted to ratify WithumSmith+Brown, PC as INVO’s independent public accountant for fiscal year 2025. In addition, the meeting included approval for the potential issuance of up to 4,733,728 shares of common stock upon exercise of a warrant that was issued to certain investors as part of a private placement transaction that closed on December 4, 2025.
Another approved measure was the fourth amendment to the company’s 2019 Stock Incentive Plan. That amendment increased the number of shares available for issuance under the plan to 1,000,000, which the company states represents approximately 10% of the total issued and outstanding stock on a fully-diluted basis.
Voting details
The special meeting recorded 944,054 shares of common stock represented, which constituted a quorum for the vote. The proposal to increase the company’s authorized common stock received 663,861 votes in favor, with 279,474 votes against and 719 abstentions.
Context for market reaction
The market move in premarket trading was reported as a 63.6% increase in the company’s share price on Tuesday. The company’s disclosure of both the charter amendment filing and the approved ancillary matters - auditor ratification, warrant exercise authorization, and expansion of the incentive plan - were included in the meeting materials and subsequent filings.
Takeaway
Shareholders approved a substantial increase to INVO Fertility’s authorized common stock and several related corporate governance and financing items at a special meeting on January 22, 2026. The company filed the required Certificate of Amendment to its Articles of Incorporation following the vote. Voting tallies and quorum information were disclosed in the meeting results.